BioAnalytix Lands Venture Capital Funding
Monday, August 20, 2012 5:35:00 AM PDT | VentureDeal
Boston, Massachusetts -- Biotechnology company BioAnalytix (no website) has received $850,000 in new venture capital funding.
BioAnalytix is developing analysis technologies for large-molecule biologic drugs and biosimilars.
Relativity Capital led the round, which included other undisclosed investors.
Proceeds purposes were not disclosed.
Email Page | Print Page